Interestingly, enrichment of the EGFR pathway was also presented in the low-risk group, and its activation was shown to sensitize NSCLC cells to ferroptosis (Poursaitidis et al., 2017). This evidence concerns the gene EGFR and non-small cell lung carcinoma.